bit.bio today launches its new Custom ioDisease Model CellsTM offering. This offering allows scientists to commission their disease-relevant mutation of interest in bit.bio's human induced pluripotent stem cell (iPSC)-derived cells powered by opti-ox technology.

uBriGene, a cell & gene therapy contract development and manufacturing organization, is expanding into the US market with the acquisition of a state-of-the-art GMP manufacturing facility from NASDAQ-listed company Mustang Bio, Inc.

Lonza has launched the TheraPEAK® T-VIVO® Cell Culture Medium, a novel chemically defined medium developed to optimize CAR T-cell manufacture.

Deepcell has announced the launch of the REM-I Platform, a high-dimensional cell morphology analysis and sorting platform which comprises the REM-I benchtop instrument, Human Foundation Model and Axon data suite.

Eppendorf introduces the Bioprocess Autosampler, which facilitates sampling 24/7 in short and regular intervals, gaining complete datasets.

Samsara Therapeutics has announced the company’s autophagy-inducing candidate SAM001, the first agent of its class to enter clinical trials.

Sphere Fluidics, a company developing single-cell analysis systems underpinned by its patented picodroplet technology, has announced its involvement in 3DSecret.

Micronic launches a new addition to its automatic recapping equipment range to accelerate sample storage workflows: the Screw Cap Recapper CS700 with Extended Height.

Ziath announces a revolution in cryogenic sample management – the Ri-Track Mirage 2D barcoded tube whole rack reader.

The Skeletal Muscle Differentiation kit from AMSBIO provides a unique protocol to differentiate human pluripotent stem cells to skeletal muscle with high yields and without cell sorting or genetic manipulation.